TD Cowen lowered the firm’s price target on Charles River to $209 from $212 and keeps a Market Perform rating on the shares. The firm updated its model following the company’s Anaalyst Day which now reflects the introduction of 2026 targets and management’s lower expectations for growth in 2024 as well as Biologics and CDMO businesses.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRL:
- Charles River price target lowered to $275 from $280 at Wells Fargo
- Charles River price target lowered to $225 from $255 at Guggenheim
- Charles River price target lowered to $256 from $267 at Baird
- Charles River price target lowered to $230 from $245 at BofA
- Charles River’s updated targets below consensus expectations, says UBS